Two pharmacists in a conversation.

Our Partnerships

Our partners are valued contributors in our global family of innovation. We are interested in partnering with organizations in the discovery, development, and commercialization of novel therapies within psychiatry and neurology. These collaborations enable us to maximize value for our patients, customers, and to support better health care.

Our Partnership Alliances

Bial
Eisai
Pari
Valera Health

Sunovion’s collaboration with Urovant Sciences supports the commercialization of GEMTESA® (vibegron) tablets, an investigational medicine for the treatment of overactive bladder.

Urovant

We are excited to work closely with our partners to launch Orgovyx™ (relugolix), a treatment for men with advanced prostate cancer.

Myovant

Partner
Submission Process

Sunovion is seeking partnerships with organizations in the discovery, development, and commercialization of therapies within psychiatry and neurology. If you're interested in partnering with us, please email your idea or proposal using this form.

1.

For In-License: Please complete the form fields below and include: Product Name, Product Indication, Stage your product is in, and Therapeutic Area.
For Out-License: Please complete the form fields below and include: Sunovion product of interest and Territory pursuing.

2.

A member of the Sunovion Business Development team will review your partner request information and respond in a timely manner.

3.

If there is an interest from Sunovion to pursue discussions, Sunovion BD will arrange a call and interested party will discuss asset and company capabilities.

4.

If the call results in pursing the partnership further, potential partner company will execute a Confidential Disclosure Agreement with Sunovion and more in-depth discussions will commence.

250 characters max [0]
1000 characters max [0]

*required